AecorBio Inc., formerly known as HBC Immunology Inc, has successfully completed a further equity financing round of $1.5m from existing and new investors at a company valuation of $30 million. This ...

CON and UK SME?ImmBio partner reach key stage in development of new pneumococcal disease vaccine: Liverpool, UK Wednesday, September 17, 2025, 12:00 Hrs [IST] The Infection Inno ...